The ‘dark’ gene CDKN1A is one of the targets associated with cell proliferation and cell cycle, and is also the promising target on which berberine may act to regulate immune responses, inflammatory processes, and cell activities against COVID-19 and SARS infection [51]. Here, CDKN1A is linked to COVID-19.